supplementhackr
Bronson

Vitamin C And Lysine 500 mg

Serving
1 Tablet(s)
Form
tablet
UPC
716563196011
DSLD
8890
Formula hash
6dcde19baded
Brand context
Bronson
Catalog
659
products
With avoid flag
68
products
FDA recalls
0
history
CAERS
1
reports
Avoid-flaggedObjective label signals
Flagged excipients
4
1 avoid · 3 caution
FDA recalls
0
no recall history
CAERS reports
1
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

2 active ingredients
IngredientAmount% DV
Vitamin C
vitaminUNII · PQ6CK8PD0R
UL · set5 effects
500 mg833%
Lysine
amino_acidUNII · K3Z4F929H6
500 mg—
What this product supports · authorized claims

5 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

4 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

    eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →
  • ◐ CAUTIONFD&C Yellow #6
    color

    EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.

    eur-lex.europa.eu →
  • ◐ CAUTIONFD&C Blue #2
    color

    Banned from direct food use in Norway; restricted in EU under Commission Regulation 1333/2008. FDA permits under 21 CFR 74.102 with labeling requirement.

    eur-lex.europa.eu →
  • ◐ CAUTIONFD&C Yellow #5
    color

    EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).

    eur-lex.europa.eu →ecfr.gov →
FDA CAERS · adverse event context
1
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Cellulose · Dicalcium Phosphate · Stearic Acid · Croscarmellose Sodium · Hydroxypropyl Cellulose · Povidone · Magnesium Stearate · Silicon Dioxide · Sodium Starch Glycolate · Hydroxypropyl Methylcellulose · polyetylene glycol · Polysorbate 80

Chemically equivalent

Same formula, different brand

Products with identical sorted (ingredient, amount) tuples.